One of the company's wholly-owned subsidiaries has commercialised Cequa 0.09 per cent in the US, Sun Pharma said in a filing to BSE.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2MIjRCp
via IFTTT
Sun Pharma launches Cequa to treat dry eye disease in US
One of the company's wholly-owned subsidiaries has commercialised Cequa 0.09 per cent in the US, Sun Pharma said in a filing to BSE.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2MIjRCp
via IFTTT
0 comments:
Post a Comment